Mr. Hanley spent 18 years at the Covidien family of companies and is the former President of Covidien’s Imaging Solutions business unit with annual global revenue exceeding $1.2 billion. He led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development. Mr. Hanley is Principal and Founder of Neem LLC which focuses on entrepreneurial medical device and life science companies.

Dr. Dorshow PhD is a research physicist and manager with over 25 years in R&D. He established and led the optical diagnostics and therapeutics program at Mallinckrodtand subsequently Covidien. He constructed its Intellectual Property position, and is co-inventor on over 60 issues US patents. Dr. Dorshow has authored over 40 technical articles in this field. Dr Dorshow will lead the R & D, clinical and regulatory efforts at MediBeacon.

Mr. Stern is a multi-lingual, global executive with a record of entrepreneurial achievement in the life sciences. As CEO and Founder of Vetbrands International he led the private equity backed buyout of Ralston Purina’s pharmaceutical business in 2002 culminating in the sale of this Brazilian business to Ceva Santé Animale in 2007. Mr. Stern held various management and development roles at Novus before joining Neem as Practice Lead in 2011.